Intraperitoneal chemotherapy comes of age

被引：36

作者：

Cannistra, SA ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 01期

关键词：

D O I：

10.1056/NEJMe058308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：77 / 79

页数：3

共 13 条

[1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].

Alberts, DS ;

Liu, PY ;

Hannigan, EV ;

OToole, R ;

Williams, SD ;

Young, JA ;

Franklin, EW ;

ClarkePearson, DL ;

Malviya, VK ;

DuBeshter, B ;

Adelson, MD ;

Hoskins, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955

[2] Intraperitoneal therapy for stage III ovarian cancer: A therapy whose time has come! [J].

Alberts, DS ;

Markman, M ;

Armstrong, D ;

Rothenberg, ML ;

Muggia, F ;

Howell, SB .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :3944-3946

[3] Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].

Armstrong, DK ;

Bundy, B ;

Wenzel, L ;

Huang, HQ ;

Baergen, R ;

Lele, S ;

Copeland, LJ ;

Walker, JL ;

Burger, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43

[4] ANATOMICAL AND PATHOLOGICAL-STUDY OF RETROPERITONEAL NODES IN EPITHELIAL OVARIAN-CANCER [J].

BENEDETTIPANICI, P ;

GREGGI, S ;

MANESCHI, F ;

SCAMBIA, G ;

AMOROSO, M ;

RABITTI, C ;

MANCUSO, S .

GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :150-154

[5] Cancer of the ovary [J].

Cannistra, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529

[6] First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up (vol 90, pg 637, 2003) [J].

Fujiwara, K ;

Sakuragi, N ;

Suzuki, S ;

Yoshida, N ;

Maehata, K ;

Nishiya, M ;

Koshida, T ;

Sawai, H ;

Aotani, E ;

Kohno, I .

GYNECOLOGIC ONCOLOGY, 2003, 91 (03) :662-662

[7] First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up [J].

Fujiwara, K ;

Sakuragi, N ;

Suzuki, S ;

Yoshida, N ;

Maehata, K ;

Nishiya, M ;

Koshida, T ;

Sawai, H ;

Aotani, E ;

Kohno, I .

GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :637-643

[8] INTRAPERITONEAL CISPLATIN WITH SYSTEMIC THIOSULFATE PROTECTION [J].

HOWELL, SB ;

PFEIFLE, CL ;

WUNG, WE ;

OLSHEN, RA ;

LUCAS, WE ;

YON, JL ;

GREEN, M .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :845-851

[9] PLATINUM DISTRIBUTION IN INTRAPERITONEAL TUMORS AFTER INTRAPERITONEAL CISPLATIN TREATMENT [J].

LOS, G ;

MUTSAERS, PHA ;

LENGLET, WJM ;

BALDEW, GS ;

MCVIE, JG .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) :389-394

[10] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group [J].

Markman, M ;

Bundy, BN ;

Alberts, DS ;

Fowler, JM ;

Clark-Pearson, DL ;

Carson, LF ;

Wadler, S ;

Sickel, J .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1001-1007

← 1 2 →